| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Photodermatology Photoimmunology and Photomedicine |
| Vol/bind | 39 |
| Udgave nummer | 1 |
| Sider (fra-til) | 66-68 |
| ISSN | 0905-4383 |
| DOI | |
| Status | Udgivet - jan. 2023 |
Bibliografisk note
Funding Information:Dr. Steven Feldman has received research, speaking, and/or consulting support from Eli Lilly and Company, GlaxoSmithKline/Stiefel, AbbVie, Janssen, Alovtech, vTv Therapeutics, Bristol‐Myers Squibb, Samsung, Pfizer, Boehringer Ingelheim, Amgen, Dermavant, Arcutis, Novartis, Novan, UCB, Helsinn, Sun Pharma, Almirall, Galderma, Leo Pharma, Mylan, Celgene, Ortho Dermatology, Menlo, Merck & Co, Qurient, Forte, Arena, Biocon, Accordant, Argenx, Sanofi, Regeneron, the National Biological Corporation, Caremark, Teladoc, Eurofins, Informa, UpToDate, and the National Psoriasis Foundation. He is the founder and part owner of Causa Research and holds stock in Sensal Health. Ms. Dao, Mr. Patel, Dr. Porter, Dr. Johnson, Mr. Vu, Mr. Dao, and Ms. Kakatkar have no conflicts to disclose.
Finansiering
Dr. Steven Feldman has received research, speaking, and/or consulting support from Eli Lilly and Company, GlaxoSmithKline/Stiefel, AbbVie, Janssen, Alovtech, vTv Therapeutics, Bristol‐Myers Squibb, Samsung, Pfizer, Boehringer Ingelheim, Amgen, Dermavant, Arcutis, Novartis, Novan, UCB, Helsinn, Sun Pharma, Almirall, Galderma, Leo Pharma, Mylan, Celgene, Ortho Dermatology, Menlo, Merck & Co, Qurient, Forte, Arena, Biocon, Accordant, Argenx, Sanofi, Regeneron, the National Biological Corporation, Caremark, Teladoc, Eurofins, Informa, UpToDate, and the National Psoriasis Foundation. He is the founder and part owner of Causa Research and holds stock in Sensal Health. Ms. Dao, Mr. Patel, Dr. Porter, Dr. Johnson, Mr. Vu, Mr. Dao, and Ms. Kakatkar have no conflicts to disclose.
Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver